Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A chitosan-mediated inhalable nanovaccine against SARS-CoV-2
Shao‐Hua Zhuo, Jun Wu, Lang Zhao, et al.
Nano Research (2022) Vol. 15, Iss. 5, pp. 4191-4200
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Nanovaccines: A game changing approach in the fight against infectious diseases
Priyanka Choudhary, Mai Abdel Haleem Abusalah, Hitesh Chopra, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115597-115597
Open Access | Times Cited: 72
SARS-CoV-2 Vaccines, Vaccine Development Technologies, and Significant Efforts in Vaccine Development during the Pandemic: The Lessons Learned Might Help to Fight against the Next Pandemic
Chiranjib Chakraborty, Manojit Bhattacharya, Kuldeep Dhama
Vaccines (2023) Vol. 11, Iss. 3, pp. 682-682
Open Access | Times Cited: 62
Functional probes for the diagnosis and treatment of infectious diseases
Zhijin Fan, Yan Liu, Yuyun Ye, et al.
Aggregate (2024)
Open Access | Times Cited: 20
Biomaterials for intranasal and inhaled vaccine delivery
Devorah Cahn, Mayowa Amosu, Katharina Maisel, et al.
Nature Reviews Bioengineering (2023) Vol. 1, Iss. 2, pp. 83-84
Open Access | Times Cited: 24
Engineering customized nanovaccines for enhanced cancer immunotherapy
JinYu Guo, Changhua Liu, Zhaoyang Qi, et al.
Bioactive Materials (2024) Vol. 36, pp. 330-357
Open Access | Times Cited: 12
Applications of Chitosan in Prevention and Treatment Strategies of Infectious Diseases
Genada Sinani, Melike Sessevmez, Sevda Şenel
Pharmaceutics (2024) Vol. 16, Iss. 9, pp. 1201-1201
Open Access | Times Cited: 8
Chitosan and its derivatives as polymeric anti-viral therapeutics and potential anti-SARS-CoV-2 nanomedicine
Rebecca Tan, Pouya Hassandarvish, Chin Fei Chee, et al.
Carbohydrate Polymers (2022) Vol. 290, pp. 119500-119500
Open Access | Times Cited: 35
Tailorable antibacterial and cytotoxic chitosan derivatives by introducing quaternary ammonium salt and sulfobetaine
Wanjing Zou, Jingwei Gu, Jianna Li, et al.
International Journal of Biological Macromolecules (2022) Vol. 218, pp. 992-1001
Closed Access | Times Cited: 33
Recent advances in respiratory immunization: A focus on COVID-19 vaccines
Xiyue He, Xiaohong Chen, Hairui Wang, et al.
Journal of Controlled Release (2023) Vol. 355, pp. 655-674
Open Access | Times Cited: 21
A state-of-the-art review on solid lipid nanoparticles as a nanovaccines delivery system
Marjan Assefi, Mehrnaz Ataeinaeini, Ahmad Nazari, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 86, pp. 104623-104623
Closed Access | Times Cited: 21
Recent advances in nano- and micro-scale carrier systems for controlled delivery of vaccines
Erika Yan Wang, Morteza Sarmadi, Binbin Ying, et al.
Biomaterials (2023) Vol. 303, pp. 122345-122345
Closed Access | Times Cited: 20
The Application of Nanovaccines in Autoimmune Diseases
Yuhong Tang, Lili Li
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 367-388
Open Access | Times Cited: 6
Rational Design of T-Cell- and B-Cell-Based Therapeutic Cancer Vaccines
Wenhao Li, Jing-Yun Su, Yanmei Li
Accounts of Chemical Research (2022) Vol. 55, Iss. 18, pp. 2660-2671
Closed Access | Times Cited: 26
Biodegradation and Prospect of Polysaccharide from Crustaceans
Shuting Qiu, Shipeng Zhou, Yue Tan, et al.
Marine Drugs (2022) Vol. 20, Iss. 5, pp. 310-310
Open Access | Times Cited: 24
Nanoparticles and Antiviral Vaccines
Sen L, Meilin Hu, Xiaoqing Liu, et al.
Vaccines (2023) Vol. 12, Iss. 1, pp. 30-30
Open Access | Times Cited: 13
Recent progress in application of nanovaccines for enhancing mucosal immune responses
Guangsheng Du, Ming Qin, Xun Sun
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 6, pp. 2334-2345
Open Access | Times Cited: 21
Self-Adjuvanting Protein Vaccine Conjugated with a Novel Synthetic TLR4 Agonist on Virus-Like Liposome Induces Potent Immunity against SARS-CoV-2
Dong Ding, Yu Wen, Chun-Miao Liao, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 2, pp. 1467-1483
Closed Access | Times Cited: 12
Inhalation drug delivery in combating pulmonary infections: Advances and challenges
Popat Kumbhar, Jaskiran Kaur, Gabriele De Rubis, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 89, pp. 105022-105022
Closed Access | Times Cited: 12
Recent Developments in Aerosol Pulmonary Drug Delivery: New Technologies, New Cargos, and New Targets
Ian R. Woodward, Catherine A. Fromen
Annual Review of Biomedical Engineering (2024) Vol. 26, Iss. 1, pp. 307-330
Closed Access | Times Cited: 4
Harnessing the immunomodulatory potential of chitosan and its derivatives for advanced biomedical applications
Doğukan Duymaz, Aybaran Olca Kebabci, Seda Kızılel
International Journal of Biological Macromolecules (2025), pp. 142055-142055
Closed Access
Exosomes-based particles as inhalable COVID-19 vaccines
Fan Lü, Li Wang, Xiaoju Wang, et al.
Biomedical Technology (2023) Vol. 4, pp. 24-27
Open Access | Times Cited: 10
Efficiency of Chitosan Nanocarriers in Vaccinology for Mucosal Immunization
Salvatore Calogero Gaglio, Massimiliano Perduca, Donato Zipeto, et al.
Vaccines (2023) Vol. 11, Iss. 8, pp. 1333-1333
Open Access | Times Cited: 10
A General Strategy toward Self‐assembled Nanovaccine Based on Cationic Lentinan to Induce Potent Humoral and Cellular Immune Responses
Ruihong Yu, Lan Jin, Zuchen Song, et al.
Small (2024) Vol. 20, Iss. 43
Closed Access | Times Cited: 3
Adjuvant-Free COVID-19 Vaccine with Glycoprotein Antigen Oxidized by Periodate Rapidly Elicits Potent Immune Responses
Ruyan Zhang, Shihao Zhou, Ran-Ran Feng, et al.
ACS Chemical Biology (2023) Vol. 18, Iss. 4, pp. 915-923
Closed Access | Times Cited: 8
Emerging Trends on Nanovaccine Administration and Functionalization Strategies for Immunization
Hitesh Kumar Dewangan, Kamal Shah, Rajiv Sharma, et al.
Journal of Computational Biophysics and Chemistry (2024) Vol. 23, Iss. 05, pp. 575-604
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top